IN2014DN08487A - - Google Patents
Info
- Publication number
- IN2014DN08487A IN2014DN08487A IN8487DEN2014A IN2014DN08487A IN 2014DN08487 A IN2014DN08487 A IN 2014DN08487A IN 8487DEN2014 A IN8487DEN2014 A IN 8487DEN2014A IN 2014DN08487 A IN2014DN08487 A IN 2014DN08487A
- Authority
- IN
- India
- Prior art keywords
- methods
- conjugates
- subject
- disclosed
- imaging
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 5
- 238000003384 imaging method Methods 0.000 abstract 2
- BQHFYSWNHZMMDO-WDSKDSINSA-N (2r)-2-[2-[[(1r)-1-carboxy-2-sulfanylethyl]amino]ethylamino]-3-sulfanylpropanoic acid Chemical compound OC(=O)[C@H](CS)NCCN[C@@H](CS)C(O)=O BQHFYSWNHZMMDO-WDSKDSINSA-N 0.000 abstract 1
- DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Novel methods of synthesis of ethylenedicysteine sugar conjugates and therapeutic and diagnostic applications of such conjugates are disclosed. Methods of synthesizing these conjugates in high purity are also presented as using starting materials such as thiazolidine carboxylic acid. Also disclosed are methods of imaging treating and diagnosing disease in a subject using these conjugates prepared herein such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615684P | 2012-03-26 | 2012-03-26 | |
| PCT/US2013/033919 WO2013148710A1 (en) | 2012-03-26 | 2013-03-26 | Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08487A true IN2014DN08487A (en) | 2015-05-08 |
Family
ID=49261180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8487DEN2014 IN2014DN08487A (en) | 2012-03-26 | 2013-03-26 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9549995B2 (en) |
| EP (1) | EP2830666B1 (en) |
| JP (1) | JP6336695B2 (en) |
| KR (1) | KR102040476B1 (en) |
| CN (1) | CN104321083B (en) |
| AU (1) | AU2013239870B2 (en) |
| BR (1) | BR112014023988B1 (en) |
| CA (1) | CA2868857C (en) |
| DK (1) | DK2830666T3 (en) |
| ES (1) | ES2782504T3 (en) |
| HU (1) | HUE048557T2 (en) |
| IL (1) | IL234858A (en) |
| IN (1) | IN2014DN08487A (en) |
| PL (1) | PL2830666T3 (en) |
| PT (1) | PT2830666T (en) |
| RS (1) | RS60085B1 (en) |
| RU (1) | RU2674673C2 (en) |
| SI (1) | SI2830666T1 (en) |
| WO (1) | WO2013148710A1 (en) |
| ZA (1) | ZA201407213B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107955053B (en) * | 2017-12-11 | 2019-10-29 | 江西宇能制药有限公司 | Preparation method of levonorgestrel intermediate ethyl lithium amide |
| WO2023077375A1 (en) * | 2021-11-04 | 2023-05-11 | Shenzhen Xpectvision Technology Co., Ltd. | In vivo xrf agent |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925650A (en) * | 1988-11-16 | 1990-05-15 | Mallinckrodt, Inc. | Technetium -99m complex for examining the renal function |
| US6407071B1 (en) * | 1998-06-04 | 2002-06-18 | Co-Enzyme Technology Ltd. | Method and composition for treating malignant cells |
| US6692724B1 (en) | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| US7067111B1 (en) * | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| JP5448284B2 (en) | 2000-06-02 | 2014-03-19 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | Ethylenedicysteine (EC) -drug conjugate |
| WO2004044227A2 (en) * | 2002-11-07 | 2004-05-27 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| JP2008531755A (en) * | 2005-01-05 | 2008-08-14 | ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム | Conjugates for dual imaging and radiation chemotherapy: composition, manufacture and indication |
| EP1926487A2 (en) | 2005-07-19 | 2008-06-04 | University of Tennessee Research Foundation | Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents |
| US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| US20080107198A1 (en) | 2006-11-07 | 2008-05-08 | Innovative Sonic Limited | Method and apparatus for performing multi-input multi-output transmission in a wireless communications system |
| WO2009120244A1 (en) | 2008-03-24 | 2009-10-01 | The Board Of Regents Of The University Of Texas System | Image-guided therapy of myocardial disease: composition, manufacturing and applications |
-
2013
- 2013-03-26 US US13/850,917 patent/US9549995B2/en active Active
- 2013-03-26 EP EP13767943.7A patent/EP2830666B1/en active Active
- 2013-03-26 RU RU2014143024A patent/RU2674673C2/en active
- 2013-03-26 CA CA2868857A patent/CA2868857C/en active Active
- 2013-03-26 HU HUE13767943A patent/HUE048557T2/en unknown
- 2013-03-26 AU AU2013239870A patent/AU2013239870B2/en active Active
- 2013-03-26 IN IN8487DEN2014 patent/IN2014DN08487A/en unknown
- 2013-03-26 CN CN201380021343.XA patent/CN104321083B/en active Active
- 2013-03-26 PL PL13767943T patent/PL2830666T3/en unknown
- 2013-03-26 SI SI201331704T patent/SI2830666T1/en unknown
- 2013-03-26 PT PT137679437T patent/PT2830666T/en unknown
- 2013-03-26 BR BR112014023988-6A patent/BR112014023988B1/en active IP Right Grant
- 2013-03-26 RS RS20200382A patent/RS60085B1/en unknown
- 2013-03-26 ES ES13767943T patent/ES2782504T3/en active Active
- 2013-03-26 JP JP2015503472A patent/JP6336695B2/en active Active
- 2013-03-26 KR KR1020147030004A patent/KR102040476B1/en active Active
- 2013-03-26 DK DK13767943.7T patent/DK2830666T3/en active
- 2013-03-26 WO PCT/US2013/033919 patent/WO2013148710A1/en active Application Filing
-
2014
- 2014-09-28 IL IL234858A patent/IL234858A/en active IP Right Grant
- 2014-10-06 ZA ZA2014/07213A patent/ZA201407213B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140144720A (en) | 2014-12-19 |
| JP2015512408A (en) | 2015-04-27 |
| BR112014023988B1 (en) | 2021-02-02 |
| JP6336695B2 (en) | 2018-06-06 |
| AU2013239870B2 (en) | 2017-07-20 |
| RS60085B1 (en) | 2020-05-29 |
| US9549995B2 (en) | 2017-01-24 |
| PL2830666T3 (en) | 2021-03-08 |
| ES2782504T3 (en) | 2020-09-15 |
| CN104321083A (en) | 2015-01-28 |
| AU2013239870A1 (en) | 2014-10-23 |
| US20130343995A1 (en) | 2013-12-26 |
| CA2868857C (en) | 2020-06-02 |
| ZA201407213B (en) | 2017-08-30 |
| HK1204567A1 (en) | 2015-11-27 |
| EP2830666A4 (en) | 2015-11-04 |
| WO2013148710A1 (en) | 2013-10-03 |
| IL234858A (en) | 2017-03-30 |
| PT2830666T (en) | 2020-04-02 |
| DK2830666T3 (en) | 2020-04-06 |
| RU2674673C2 (en) | 2018-12-12 |
| CA2868857A1 (en) | 2013-10-03 |
| SI2830666T1 (en) | 2020-07-31 |
| EP2830666B1 (en) | 2020-01-08 |
| RU2014143024A (en) | 2016-05-20 |
| HUE048557T2 (en) | 2020-07-28 |
| KR102040476B1 (en) | 2019-11-06 |
| EP2830666A1 (en) | 2015-02-04 |
| CN104321083B (en) | 2017-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL240828A0 (en) | Methods of manufacture and synthesis of amino acid linking groups conjugated to compounds used for targeted imaging of tumors | |
| CO6511271A2 (en) | IMIDAZOPIRIDINIL-AMINOPIRIDINE SUBSTITUTED COMPOUNDS | |
| PH12015501092A1 (en) | Anti-ceacam5 antibodies and uses thereof | |
| EA201590783A1 (en) | CONJUGATES FOR DELIVERY OF MEDICINES AND METHODS OF TREATMENT OF DISEASES CAUSED BY CELLS EXPRESSING PSMA | |
| EA201270824A1 (en) | COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS | |
| MX353482B (en) | METHODS FOR THE TREATMENT OF CANCER and INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR. | |
| BR112012016376A2 (en) | substituted pyrrolo-aminopyrimide compounds | |
| IN2014CN04961A (en) | ||
| HK1202450A1 (en) | Pyridinamide and the like which exhibit anticancer and antiproliferative activities | |
| IN2014DN06164A (en) | ||
| IL226975B (en) | Low dose pioglitazone for diagnosis and treatment of alzheimer’s disease | |
| CA2889275C (en) | Novel method for treating cardiac infarction using hmgb1 fragment | |
| IN2015DN01119A (en) | ||
| NZ602992A (en) | Prophylaxis of colorectal and gastrointestinal cancer | |
| MX347734B (en) | S100a4 antibodies and therapeutic uses thereof. | |
| GB201112246D0 (en) | Diagnosis of alzheimer's disease | |
| WO2009103741A3 (en) | Use of fsh receptor ligands for diagnosis and therapy of cancer | |
| WO2011044410A3 (en) | Solid phase extraction purification method | |
| SG10201810357WA (en) | Ly75 as cancer therapeutic and diagnostic target | |
| IN2014DN08379A (en) | ||
| IN2014DN08487A (en) | ||
| WO2012061342A3 (en) | Substituted benzo-imidazo-pyrido-diazepine compounds | |
| MX2013003859A (en) | Picropodophyllin polymorphs b or c for use in cancer therapy. | |
| NZ708849A (en) | Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma | |
| NZ609924A (en) | Porphyrin treatment of neurodegenerative diseases |